An Erk/Cdk5 axis controls the diabetogenic actions of PPARγ
Obesity-linked insulin resistance is a major precursor to the development of type 2 diabetes. Previous work has shown that phosphorylation of PPARγ at serine 273 by Cdk5 stimulates diabetogenic gene expression in adipose tissues1. Inhibition of this modification is a key therapeutic mechanism for an...
Main Authors: | Banks, Alexander S., McAllister, Fiona E., Camporez, João Paulo G., Zushin, Peter-James H., Jurczak, Michael J., Laznik-Bogoslavski, Dina, Shulman, Gerald I., Gygi, Steven P., Spiegelman, Bruce M. |
---|---|
Format: | Online |
Language: | English |
Published: |
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297557/ |
Similar Items
-
Anti-Diabetic Actions of a Non-Agonist PPARγ Ligand Blocking Cdk5-Mediated Phosphorylation
by: Choi, Jang Hyun, et al.
Published: (2011) -
CDK5 promotes renal tubulointerstitial fibrosis in diabetic nephropathy via ERK1/2/PPARγ pathway
by: Bai, Xiaoyan, et al.
Published: (2016) -
Statin diabetogenicity: guidance for clinicians
by: Ray, Kausik
Published: (2013) -
COMPARATIVE DIABETOGENIC ACTION OF THE HYPOPHYSIS FROM VARIOUS ANIMALS
by: Houssay, B. A., et al.
Published: (1942) -
Diabetogenic Effect of Statins: A Double-Edged Sword?
by: Yoon, Ji Sung, et al.
Published: (2013)